Stearic acid is toxic for T lymphocytes in vitro but has little effect on B lymphocytes. To investigate the molecular basis for this difference, purified murine T and B lymphocytes were compared for their abilities to incorporate and metabolize stearic acid. Unstimulated T and B cells incorporated identical amounts of stearic acid into six different phospholipids and four neutral lipids. After mitogen stimulation, fatty acid uptake was increased in both lymphocyte types, but cell-specific differences were seen in the distribution of stearic acid among the various cellular lipids. Doses of stearic acid that selectively inhibited T-cell proliferation resulted in a 5-fold greater accumulation of distearoylphosphatidylcholine in T cells than in B cells. Whereas T cells did not desaturate the exogenously derived stearic acid, up to 25% of the saturated fatty acid was converted to oleic acid in B cells. These findings suggested a deficiency of stearoyl-CoA desaturase (acyl-CoA, hydrogen-donor:oxygen oxidoreductase, EC 1.14.99.5) activity in T cells, which was confirmed by subsequent studies. Cell-free extracts from B cells displayed nearly 20-fold more stearoylCoA desaturase activity than T-cell extracts, and the level of stearoyl-CoA desaturase mRNA was 30-fold higher in B cells. Collectively, our data indicate that murine T cells are deficient in unsaturated fatty acid synthesis. The deficiency of stearoylCoA desaturase in T cells may represent the basis for the differing sensitivities of T and B lymphocytes to inhibition by saturated fatty acids.
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Saturated and unsaturated fatty acids markedly affect lymphocyte function both in vivo and in vitro (for review, see refs. [1] [2] [3] . In general, saturated fatty acids and high levels (>20 AuM) of unsaturated fatty acids are inhibitory, whereas low amounts (<10 ,M) of unsaturated fatty acids enhance lymphocyte growth and function (4) (5) (6) (7) (8) . The mechanisms by which fatty acids alter lymphocyte function are not fully understood. Polyunsaturated fatty acids are converted to various icosanoids having potent immunopharmacological properties (9, 10) . By contrast saturated and monounsaturated fatty acids have been proposed to act by changing the organization or physical properties of immune cell membranes, although this remains controversial (3, 10, 11) .
In studies carried out in vivo (3, 12, 13) and in vitro (8, 14) , fatty acids have been shown to have a greater effect on T cells and cell-mediated immunity than on B cells and humoral immunity. For example, using highly purified murine T and B lymphocytes, we showed that stearic acid potently inhibited T-cell proliferation but had much less effect on B-cell proliferation (8) . At the same concentration (50AM), oleic acid was without effect; however, when added simultaneously with stearic acid, oleic acid could obviate the inhibitory effects of the saturated fatty acid (8, 15) . Subsequent studies regarding the effects of free fatty acids on in vitro primary antibody responses provided results consistent with our earlier findings where stearic acid was shown to inhibit thymus-dependent but not thymus-independent antibody responses (14) . More recently we have obtained additional evidence implicating T helper cells as the target for saturated fatty acid inhibition in primary antibody responses (S. Pourbohloul and T.M.B., unpublished observations).
The differential effect of saturated fatty acids on T and B cells suggests that the two lymphocyte types differ either in fatty acid uptake and utilization or in their abilities to tolerate changes in membrane fatty acid composition. To address this question, we have compared purified B and T lymphocytes for their abilities to incorporate and metabolize exogenous stearic acid. Because the initial results of this work indicated that T cells were unable to desaturate stearic acid to yield oleic acid, subsequent studies were undertaken to compare B and T cells for their levels of stearoyl-CoA desaturase (acyl-CoA, hydrogen-donor:oxygen oxidoreductase, EC 1.14.99.5). The results reported here demonstrate a fundamental difference in lipid metabolism between B and T lymphocytes.
MATERIALS AND METHODS
Lymphocyte Isolation and Culture. Purified T and B lymphocytes were isolated from spleens of 8-to 12-week-old BALB/c mice (Charles River Breeding Laboratories) as described (16) . As demonstrated by immunofluorescence studies, the recovered B-and T-cell populations were typically >97% positive for surface immunoglobulin or Thy 1.2, respectively (16) . Lymphocytes were cultured and assayed for proliferation as described (16 (18) . Radiolabeled lipids were quantified using a RITA linear radioactivity detector (Raytest, Muenster, F.R.G.).
For analysis of molecular species, radiolabeled phosphatidylcholine fractions were converted to diacylglycerides by phospholipase C digestion (19) followed by benzylation (20, 21) . The benzylated (20) or dinitrobenzylated (21) quantitated by collection of 1-ml fractions, which were dried before liquid scintillation counting. Molecular species were identified by comparing their retention volumes to those of known authentic standards, as well as by gas/liquid chromatography analysis (22) of the fatty acyl methyl esters obtained following transesterification [5% (vol/vol) HCl/ methanol for 2 hr at 750C] of the recovered molecular species.
Isolation and Assay of Stearoyl-CoA Desaturase Activity.
Approximately 1 x 108 B orT lymphocytes were washed with phosphate-buffered saline (pH 7.2) and resuspended in 10 mM Tris buffer (pH 7.6) containing 0.5 mM MgCl2 and phenylmethanesulfonyl fluoride at 150 Mug/ml. The cell suspension was sonicated for 5 sec by using a Biosonik III sonicator (Bronwill) set at maximum output. After centrifugation of the suspension (10 min at 2000 x g, 40C), the recovered membrane pellet was resuspended in the Tris buffer, and protein was measured by a modified Lowry procedure (23) .
Stearoyl-CoA desaturase activity was measured by assay- The cell pellet was lysed in guanidinium isothiocyanate (25) and loaded onto a cushion of 5.7 M CsCl containing 100 mM EDTA. The RNA was collected by ultracentrifugation at 30,000 x g for 48 hr. After ethanol precipitation, the RNA pellet was resuspended in Tris/EDTA buffer (10 mM Tris, pH 7.6/1 mM EDTA). Poly(A)+ RNA was isolated, the concentration was determined by UV spectrophotometry, and 2-5 ,ug of poly(A)+ RNA was denatured with formaldehyde/formamide and electrophoresed in 1.2% agarose gels containing formaldehyde as described (26) . Blotting of RNA gels was performed by standard procedures (26) . The size of mRNA transcripts encoding stearoyl-CoA desaturase and ,8-actin were determined by linear regression analysis, with use of an ethidium bromide-stained 0.24-to 9.5-kilobase (kb) RNA ladder (BRL).
A cDNA probe for stearoyl-CoA desaturase was provided by Philipp Strittmatter (University of Connecticut, Farmington) (27) , and a chicken f-actin probe was purchased from Oncor (Gaithersburg, MD). The probes were labeled by random priming (28) ,g/ml, 0.05 M sodium phosphate buffer (pH 7), sodium pyrophosphate at 0.5 mg/ml, and 1% SDS. Hybridization was performed in the same solution except that the Denhardt's solution was 1x, and -2.5 x 107 cpm of denatured probe was added. Hybridizatipn was allowed to occur for 16-20 hr at 42°C. After hybridization, the filters were washed (final wash was at 65°C in 0.1 x SSC/0.1% SDS), wrapped in plastic wrap, and put in a DuPont Cronex cassette with Lightning Plus intensifying screens for 1-3 days at -70°C. Intensities of hybridization were determined by scanning autoradiographs with a Zeineh soft laser densitometer (Biomed Instruments, Fullerton, CA).
Statistical Analyses. Differences in lipid composition between unstimulated versus stimulated lymphocytes or between stearic acid-treated and -untreated lymphocytes were tested for significance (P < 0.05) by two-tailed, paired Student's t tests. Fig. 1 shows that resting B and T cells incorporated similar amounts of [1-14Clstearic acid into the various phospholipids and neutral lipids. In both lymphocyte types, phosphatidylcholine was the major (60-65%) phospholipid labeled, whereas fatty acids were the major (60-65%) neutral lipid species labeled. The nearly identical incorporation of [1-14C] stearic acid into the resting T-and B-cell lipids is consistent with our previous finding that stearic acid is not toxic for unstimulated lymphocytes of either type (22) .
RESULTS
In LPS-activated B cells and PHA-activated T cells, [1-14C] stearic acid incorporation into each of the phospholipids and neutral lipids (except fatty acids) was increased within 6-8 hr after mitogen addition (Fig. 1) . The activated T cells incorporated 1.5-to 2-fold more fatty acid than activated B cells. However, based on [3H]thymidine uptake measurements (=95,000 cpm for untreated, LPS-activated B cells; -150,000 cpm for untreated, PHA-activated T cells), the difference in fatty acid uptake probably reflects the proportions of B or T cells activated by the two mitogens. Thus, the selective toxicity of stearic acid towards T cells could not be correlated with differences in fatty acid uptake by the two lymphocyte types.
Changes in Phospholipid Molecular Species in Stearic AcidTreated B and T Cells. Although B and T lymphocytes incorporated nearly identical amounts of [1-14C] stearic acid into the various cellular lipids, preliminary studies suggested that B and T cells incorporated the fatty acid into distinct phospholipid molecular species. Therefore, mitogenstimulated B and T lymphocytes were recovered after overnight (16-hr) incubation in the absence or presence of 50 ,uM stearic acid, and their phosphatidylcholine molecular species were quantified. Mitogen-activated T and B cells incubated for 16 hr without stearic acid contained 16 different phosphatidylcholine molecular species, with palmitic acid/oleic acid and stearic acid/linoleic acid (in a ratio of 3:1) being the predominant species (Fig. 2A) . Overnight supplementation of T cells with 50 MuM stearic acid resulted in a significant (P < 0.0001) decrease in palmitic acid/oleic acid, with concomitant increases in stearic acid/oleic acid (P < 0.005) and distearoylphosphatidylcholine (P < 0.02) (Fig. 2B) . B cells incubated with 50 MuM stearic acid (Fig. 2C ) also displayed a decrease in palmitic acid/oleic acid (P < 0.003) and a corresponding increase in stearic acid/oleic acid (P < 0.02), but the small increase of distearoylphosphatidylcholine observed was not significant (P = 0.13). Thus, after a 16-hr incubation in the presence of 50MM stearic acid, roughly 30%o of T-cell phosphatidylcholine was in the distearoyl form, whereas this same species accounted for <8% of the total phosphatidylcholine molecular species of B cells.
Desaturation of Exogenously Derived Stearic Acid by B and T Cells. To determine the basis for the greater accumulation of distearoylphosphatidylcholine in T cells, T and B lymphocytes were compared subsequently for possible differences in their abilities to desaturate exogenously derived [1- 14C]stearic acid to yield [1-14C] wherein radiolabeled unsaturated fatty acids accounted for only 1-2% of total radiolabeled phospholipid fatty acids. The data in Fig. 3 also show that this difference was seen between resting as well as mitogen-stimulated T and B cells. Additional studies involving longer incubation times (13, 16 , and 21 hr) yielded similar results (data not shown).
Stearoyl-CoA Desaturase Activity in B and T Cells. To confirm the apparent absence of oleic acid synthesis in T cells, cell-free extracts were prepared from unstimulated as well as mitogen-stimulated B and T cells and assayed for stearoyl-CoA desaturase activity. Cell-free extracts prepared from unstimulated and LPS-activated B cells displayed >20 times more stearoyl-CoA desaturase activity than did extracts prepared from either unstimulated or Con A-stimulated T cells (Table 1) . Similar data were obtained with PHA- stimulated T cells (data not shown). These results are consistent with the data obtained with intact cells and demonstrate a near total absence of stearoyl-CoA desaturase activity in resting and activated T lymphocytes.
Levels of Stearoyl-CoA Desaturase mRNA in B and T Cells. Poly(A)+ RNA isolated from unstimulated and mitogenactivated B and T cells was subjected to Northern (RNA) analyses by using a cDNA probe for stearoyl-CoA desaturase (27) . Fig. 4 shows that the desaturase cDNA probe hybridized to a single mRNA species with the expected size of =5 kb (29, 30) . Fig. 4 also shows that desaturase mRNA was present in both resting and LPS-stimulated B cells, but was virtually absent from resting and Con A-stimulated T cells.
By comparison with f3-actin mRNA, which was expressed equally in B and T cells, resting and stimulated B cells contained >30 times more stearoyl-CoA desaturase mRNA than resting or activated T cells. These data are consistent with the demonstrated inability ofT cells to desaturate stearic acid.
DISCUSSION
The results described in this study provide evidence that murine T cells are deficient in unsaturated fatty acid synthesis. The ability of lymphocytes to incorporate and use exogenously derived free fatty acids has been reported by numerous workers, as has enhanced fatty acid uptake after mitogen activation (5, (31) (32) (33) (35, 36) . This level is equivalent to the amount of distearoylphosphatidylcholine observed in the stearic acid-treated T cells. If the accumulation of distearoylphosphatidylcholine is, in fact, responsible for the toxicity of stearic acid to T cells, then the ability of B cells to avoid the synthesis of the toxic lipid species may stem from their ability to desaturate stearic acid to yield oleic acid. We have previously reported that the simultaneous addition of oleic acid obviates the otherwise toxic effects of the stearic acid (15) , and we have recently found that T cells supplemented with both stearic and oleic acids do not accumulate distearoylphosphatidylcholine (T.M.B., unpublished observations).
The finding that murine T cells do not synthesize olefinic fatty acids is surprising but, nevertheless, agrees with reports that T cells require exogenous unsaturated fatty acids for growth in vitro. Several studies have shown that the addition of either albumin-associated unsaturated fatty acids (4, 6) or complex lipids containing olefinic acyl chains (37) (38) (39) to serum-free culture medium significantly improved human and murine lymphocyte proliferation in vitro. Indeed, unsaturated fatty acids may even be essential for PHA-induced proliferation of human T cells cultured in serum-free medium (4, 37) . Thus, the demonstrated inability of T cells to synthesize unsaturated fatty acids is consistent with the previous studies.
Changes in the levels of dietary fat can profoundly alter immune responses in vivo, and it has been suggested that T cells are the predominant sensitive immune cell population (3). Whether T lymphocytes are also dependent upon exogenous unsaturated fatty acids for proliferation and function in vivo is not known. If T cells are so dependent, the ability of B cells to synthesize monounsaturated fatty acids may enable them to "fine-tune" the lipid composition of B cells, thereby preserving permissive membrane properties.
